Daisy Manalel, PA
Physician Assistant · Rockwall, TXNPI 1962773762
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.3% of the total across 376 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 13.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,050, 6.9 times the $439 reported in 2023. Among physician assistant clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 376 payments — averaging $14.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$730
- Lilly USA, LLC$495
- Axsome Therapeutics, Inc.$479
- Pfizer$364
- Corcept Therapeutics$339
- Amgen$335
- plus $3K from 30 others
What the payments were for
- Food & beverage$5,24898%
- Education$932%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 100 | $730 |
| Lilly USA, LLC | 47 | $495 |
| Axsome Therapeutics, Inc. | 18 | $479 |
| Pfizer | 22 | $364 |
| Corcept Therapeutics | 9 | $339 |
| Amgen | 28 | $335 |
| Astellas Pharma US Inc | 12 | $282 |
| GSK | 18 | $256 |
| Sumitomo Pharma America, Inc. | 18 | $232 |
| Novo Nordisk | 14 | $227 |
| Kowa Pharmaceuticals America, Inc. | 12 | $208 |
| Otsuka America Pharmaceutical, Inc. | 8 | $172 |
| Johnson & Johnson | 6 | $123 |
| Exact Sciences | 6 | $113 |
| Optinose US, Inc. | 5 | $105 |
| Antares Pharma, Inc. | 5 | $87 |
| Abbott | 4 | $87 |
| Tris Pharma Inc | 4 | $82 |
| Phathom Pharmaceuticals, Inc. | 8 | $69 |
| Idorsia Pharmaceuticals US Inc | 4 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $62 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $48 |
| AstraZeneca | 3 | $45 |
| Bayer | 3 | $45 |
| Shield Therapeutics Inc | 2 | $41 |
| Halozyme Inc | 3 | $40 |
| Tonix Medicines, Inc. | 2 | $36 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $28 |
| Lundbeck LLC | 1 | $27 |
| Medtronic | 1 | $22 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Azurity Pharmaceuticals, Inc. | 1 | $18 |
| Merck | 1 | $17 |
| Noven Therapeutics, LLC | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| Dynavax Technologies Corporation | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Korlym$118
How this compares
$5,342 in reported general payments places this provider in the 90th percentile of 8,308 physician assistant providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 41 | $35,590 |
| OzempicSemaglutide | 15 | $20,168 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 25 | $16,697 |
| FarxigaDapagliflozin Propanediol | 12 | $12,307 |
| EliquisApixaban | 11 | $9,808 |
| Repatha SureclickEvolocumab | 16 | $9,398 |
| Rosuvastatin Calcium | 155 | $1,922 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $1,464 |
| Atorvastatin Calcium | 109 | $848 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 11 | $815 |
| Losartan Potassium | 120 | $802 |
| Humulin NInsulin Nph Human Isophane | 14 | $705 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 27 | $650 |
| Quetiapine Fumarate | 12 | $567 |
| Montelukast Sodium | 76 | $563 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $227 | $20,16815 claims |
| GSKTrelegy Ellipta | $256 | $16,69725 claims |
| AstraZenecaFarxiga | $45 | $12,30712 claims |
| PfizerEliquis | $364 | $9,80811 claims |
| Lilly USA, LLCHumulin N | $495 | $70514 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,308 physician assistant providers in Texas.
Other physician assistant in Rockwall
- Cynthia TrickettDallas$1.3M
- Kristine KuceraMelissa$797K
- Selina SantosAustin$543K
- Matthew BrunoMcKinney$538K
- Brooke HodnickSouthlake$479K
- Holly GloverArlington$418K
- Kirk GautierAthens$416K
- Jaime RomanPlano$338K
- Michael WhiteDallas$276K
- Heidi JeffreysLubbock$259K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.